Browse studies

Find your next paid study

27,292 recruiting studies available now

A Placebo-controlled, Parallel-group, Double Blind, Randomized, Multi-cohort Phase 2 Study to Investigate Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BAY 3670549 in Adult Participants With Atrial Fibrillation.

The main goal of this study is to find out how well BAY 3670549 works, how safe it is, how well people can tolerate it, and how the body handles the medicine. …

Atrial Fibrillation

Estimated

~$75 – $3,000

Actual pay is set by the research site.

BayerNCT07625215

Observational

Cancer Pain 101: A Digital, Asynchronous Intervention of Pain Management in Advanced Cancer

This is a Stage 1 study of a behavioral intervention, which means that a new intervention is being pilot tested to understand whether it is acceptable and feas…

CancerPainAdvanced Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Alabama at BirminghamNCT07852468

Phase 1

Window of Opportunity Study of Lixumistat in Patients With Newly Diagnosed Glioblastoma

The purpose of this study is to determine the effect of Lixumistat in patients with newly diagnosed Glioblastoma.

Glioblastoma

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Macarena De La Fuente, MDNCT07884344

Phase 3

Randomized, Prospective, Double Blind, Multi-Center, Phase 3 Pivotal Clinical Trial to Compare Efficacy and Safety of CARTISTEM® and Surgical Comparator in Subjects With Knee Cartilage Lesions and Osteoarthritis

To establish the efficacy and safety of CARTISTEM®, a combination product composed of allogeneic human umbilical cord blood-derived mesenchymal stem cells (hUC…

Knee Cartilage Defects

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Medipost, Inc.NCT07339111

Phase 1

Transplantation of CRISPRCas9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease

This is an open label, non-randomized, 2-center, phase 1/2 trial of a single infusion of sickle allele modified cluster of differentiation (CD34+) hematopoieti…

Sickle Cell Disease

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Mark Walters, MDNCT04774536

Phase 3

Efficacy of Intravenous Sub-Dissociative Ketamine Versus Intravenous Morphine in Children With Acute Pain

Pain is common in children presenting to the emergency department but is frequently undertreated, leading to both short- and long-term consequences. Morphine i…

Abdominal PainIsolated Extremity FracturePain+1 more

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Columbia UniversityNCT06835504

Phase 1

A Randomized, Double-blind, Placebo-controlled Single Ascending Dose and Open-label Multi-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ALN-APP in Adult Patients With Early-onset Alzheimer's Disease (EOAD)

The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of a single dose and multiple doses of ALN-A…

Early-Onset Alzheimer Disease

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Alnylam PharmaceuticalsNCT05231785

Observational

The Effect of the Safe and Sound Protocol on Depression and Anxiety Symptoms

The goal of this study is to determine if a developed protocol involving modulated auditory stimulation is better than non-modulated auditory stimulation in re…

AnxietyDepression

Estimated

~$10 – $1,125

Actual pay is set by the research site.

HealthPartners InstituteNCT06701578

Phase 1

A Phase 1, Randomized, Double-Blind, Comparator-Controlled Dose-Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of V132 in Healthy Older Participants

The goal of this study is to learn about the safety and immune response to the V132 vaccine in healthy older adults.

Healthy

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT07712575

Phase 3

Phase 3, Open-label, Single-dose, Multicenter Study Investigating Efficacy, Safety, and Tolerability of CSL222 (Etranacogene Dezaparvovec) Administered to Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

This is a phase 3, prospective, open-label, single-arm, single-dose, multicenter study investigating the efficacy, safety, and tolerability of CSL222 (AAV5-hFI…

Hemophilia B

Estimated

~$50 – $2,250

Actual pay is set by the research site.

CSL BehringNCT07080905

Observational

Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response

The goal of this study is to investigate whether the therapeutic response of pancreatic tumors can be accurately assessed using quantitative DCE-MRI, when the …

Pancreatic Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Ohio State UniversityNCT04588025

Phase 2

Cashew Allergy Study in Children: Assessing Desensitization, Efficacy, and Safety (CASCADES Study)

The CASCADES study will investigate the safety and efficacy of sublingual immunotherapy (SLIT) for the treatment of cashew allergy in children ages 1-11 years …

Cashew Nut AllergyTree Nut Allergies

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of North Carolina, Chapel HillNCT07170540